General
Australian managing partner of McKinsey regrets consultancy’s role during opioid epidemic
A damaging exposé has revealed how international consulting firm McKinsey & Company tried to pump up sales of an addictive painkiller during the opioid epidemic.
Key points:
- Consultancy firm McKinsey advised Purdue Pharma on how to increase the market share of its painkiller, OxyContin, at the height of the opioid crisis
- Its advice included offering rebates for OxyContin overdoses
- A McKinsey Australia spokesperson acknowledged a Zoom meeting was held after the revelations, saying it was part of a commitment to consider broader societal impacts of the firm’s work
After the news broke in The New York Times, the firm was in damage control and it sought to explain itself to its Australian workforce.
On a Monday earlier this month, Australian…
Continue Reading
-
Noosa News24 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News23 hours agoAustralia Post reintroduces weekend deliveries for Christmas parcel rush
-
Business22 hours agoWhy this investing expert is calling time on NAB shares
-
General19 hours agoFederal government funding extends cohealth GP services until July 2026